| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2014.02.083 |
| P698 | PubMed publication ID | 24699469 |
| P2093 | author name string | Wangxue Chen | |
| Greg Harris | |||
| Rhonda KuoLee | |||
| H Howard Xu | |||
| Hongbin Yan | |||
| Girishchandra B Patel | |||
| Wayne J Conlan | |||
| P2860 | cites work | Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection | Q28478751 |
| Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge | Q28743895 | ||
| Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy | Q33725674 | ||
| Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii | Q34484474 | ||
| Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance | Q35139329 | ||
| Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. | Q35689459 | ||
| Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice | Q35783786 | ||
| Interleukin 1: an important mediator of host resistance against Pneumocystis carinii | Q36231708 | ||
| Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. | Q36277390 | ||
| Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice | Q36314004 | ||
| Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo | Q36368755 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes | Q36569183 | ||
| A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain | Q37036579 | ||
| Therapeutic options for Acinetobacter baumannii infections | Q37099006 | ||
| Emerging therapies for multidrug resistant Acinetobacter baumannii | Q38073927 | ||
| Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes | Q38461269 | ||
| Multiple loss of effector cell functions in FcR gamma-deficient mice | Q41180664 | ||
| The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor | Q42428390 | ||
| Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital | Q43756833 | ||
| Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by Gram-negative sepsis: studies in p47phox-/- and gp91phox-/- mice | Q43950673 | ||
| Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap) | Q61704738 | ||
| Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline | Q64126896 | ||
| Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host geneti | Q73816633 | ||
| Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome | Q79846012 | ||
| Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine | Q82280648 | ||
| Role of neutrophils and NADPH phagocyte oxidase in host defense against respiratory infection with virulent Francisella tularensis in mice | Q83324130 | ||
| 3',5'-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection | Q84250609 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| immunization | Q1415366 | ||
| Acinetobacter baumannii | Q3241189 | ||
| P304 | page(s) | 260-267 | |
| P577 | publication date | 2014-03-31 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice | |
| P478 | volume | 33 |
| Q26996396 | Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity |
| Q36256352 | Current advances and challenges in the development of Acinetobacter vaccines |
| Q38772553 | Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate |
| Q40668574 | Host resistance to intranasal Acinetobacter baumannii reinfection in mice |
| Q35887251 | Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology |
| Q36555685 | Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii |
| Q40700556 | OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections |
| Q92404420 | The Mechanisms of Disease Caused by Acinetobacter baumannii |
| Q40207057 | Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection |
Search more.